|
HY-103332-10mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-100mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-25mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-5mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-50mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-114226-10mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-100mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-25mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-5mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-50mg
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1]
|
|
Cancer-programmed cell death
|
|
|
HY-114226-1mL
|
MedChemexpress LLC
|
Olutasidenib [CAS 1887014-12-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-10224-10mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-100mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-200mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-5mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-50mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-500mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10224-1mL
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-109068A-10mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-100mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-25mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-5mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-50mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068-1mg
|
MedChemexpress LLC
|
Parsaclisib [CAS 1426698-88-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068-10mg
|
MedChemexpress LLC
|
Parsaclisib [CAS 1426698-88-5]
|
|
Cancer-Kinase/protease
|
|
